Skip to main content
Premium Trial:

Request an Annual Quote

Informax Licenses Genomax to Cellular Genomics

NEW YORK, May 14 – Bioinformatics company Informax said Monday it signed a deal in the first quarter to license its Genomax software to Cellular Genomics.

An Informax spokeswoman said the deal was recorded in the company’s first quarter earnings although the official announcement was held up due to internal delays.

“These products will form a key element of CGI's bioinformatics infrastructure, allowing us to rapidly meet our needs of high throughput sequence analysis for our protein-protein interaction screens, as well as gene expression analysis for our target validation work,” Andy Whitney, Cellular Genomics’ director of bioinformatics, said in a statement.

Terms of the deal were not disclosed.

Genomax is an enterprise system that supports high-throughput research. Genomax can handle genomic and proteomic data, including sequence information, gene expression data, and protein structure.

To date, Informax of Bethesda, Md., has licensed Genomax to over 30 pharmaceutical, biotechnology, and academic customers.

Cellular Genomics of Branford, Conn., identifies and validates novel drug targets and plans to develop its own pharmaceutical products.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.